Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306) / Liu, C; You, H; Zeng, Ql; Wong, Yj; Wang, Bq; Grgurevic, I; Liu, Ch; Yim, Hj; Gou, W; Dong, Bt; Ju, Sh; Guo, Yn; Yu, Q; Hirooka, M; Enomoto, H; Hanafy, As; Cao, Zj; Dong, Xm; Lv, J; Kim, Th; Koizumi, Y; Hiasa, Y; Nishimura, T; Iijima, H; Xu, Cj; Dai, Eh; Lan, Xl; Lai, Cx; Liu, Sr; Wang, F; Guo, Y; Lv, Jj; Zhang, Lt; Wang, Yq; Xie, Q; Shao, Cx; Liu, Zs; Ravaioli, F; Colecchia, A; Li, J; Teng, Gj; Qi, Xl. - In: CLINICAL AND MOLECULAR HEPATOLOGY. - ISSN 2287-2728. - 31:1(2025), pp. 105-118. [10.3350/cmh.2024.0198]
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306).
Colecchia, A;
2025
| File | Dimensione | Formato | |
|---|---|---|---|
|
cmh-2024-0198.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
2.83 MB
Formato
Adobe PDF
|
2.83 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
